DoD Breast Cancer, Era of Hope Scholar Award | W81XWH 20 BCRP EOHS

Opportunity Information: Apply for W81XWH 20 BCRP EOHS

The DoD Breast Cancer Era of Hope Scholar Award is a funding opportunity from the Department of Defense (Department of the Army, USAMRAA) designed to support early career investigators who show unusual promise to make a real, field-shifting impact on breast cancer. The program is built around the idea that the person matters as much as, or more than, the specific project. In other words, this award is meant to identify and empower researchers who consistently demonstrate exceptional creativity, vision, innovation, productivity, and the ability to build strong collaborations, with clear potential to become future leaders in breast cancer research.

A central expectation is that the Principal Investigator (PI) will bring thinking that goes beyond the conventional playbook. Applications are expected to present a clear, compelling research vision that challenges existing dogma and shows an ability to look past traditional approaches. The program explicitly encourages bold, imaginative scientific direction, emphasizing what new or distinctive contribution the PI can make toward the long-term goal of ending breast cancer rather than simply extending established lines of work.

Importantly, prior experience in breast cancer research is not required. Applicants from other scientific or technical disciplines are encouraged to apply if they can bring novel concepts, tools, or frameworks to breast cancer. Even so, the work proposed under the application must be focused on breast cancer, and the PI is required to commit at least 50 percent of their full-time professional effort to breast cancer research during the award period. That 50 percent commitment can be met through a combination of support from this award and other existing funding, but the underlying requirement is that breast cancer research must be a major professional focus while the award is active.

Team science and meaningful stakeholder input are built into the structure of the award. The PI is encouraged to assemble a research team with the expertise and collaborative capacity needed to accomplish the proposed goals. A non-negotiable requirement is that the research team includes at least two breast cancer consumer advocates. These advocates must be lay representatives who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role must be independent of their employment, and they cannot be employees of any organization participating in the application. The intent is for advocates to provide objective, patient-centered input across the research effort, with a particular focus on relevance, feasibility, and the potential real-world impact for people living with breast cancer or those at risk.

From an administrative standpoint, this opportunity is categorized as discretionary funding and supports projects through grants and/or cooperative agreements under the Science and Technology and other Research and Development activity area (CFDA 12.420). Eligibility is described as unrestricted, meaning it is broadly open to many entity types, subject to any additional eligibility clarifications in the full announcement. The opportunity number is W81XWH 20 BCRP EOHS. The posting lists an estimated two awards, with an award ceiling shown as 0 in the source data (typically indicating that applicants must refer to the full program announcement for budget limits or that limits vary by allowable costs). The opportunity was created on December 23, 2019, with an original closing date of March 26, 2020.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Breast Cancer, Era of Hope Scholar Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Dec 23, 2019.
• Applicants must submit their applications by Mar 26, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 2 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 20 BCRP EOHS

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: